188 related articles for article (PubMed ID: 1681491)
1. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
[TBL] [Abstract][Full Text] [Related]
2. PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.
Tainsky MA; Krizman DB; Chiao PJ; Yim SO; Giovanella BC
Anticancer Res; 1988; 8(5A):899-913. PubMed ID: 3052262
[TBL] [Abstract][Full Text] [Related]
3. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
4. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
Isom HC; Woodworth CD; Meng Y; Kreider J; Miller T; Mengel L
Cancer Res; 1992 Feb; 52(4):940-8. PubMed ID: 1371091
[TBL] [Abstract][Full Text] [Related]
5. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.
Baselga J; Maerz WJ; Moy D; Miller WH; Castro L; Reuter VE; Yao TJ; Masui H; Dmitrovsky E
Oncogene; 1993 Dec; 8(12):3257-63. PubMed ID: 8247529
[TBL] [Abstract][Full Text] [Related]
7. Causal role for an activated N-ras oncogene in the induction of tumorigenicity acquired by a human cell line.
Tainsky MA; Shamanski F; Blair D; Giovanella BC
Cancer Res; 1987 Jun; 47(12):3235-8. PubMed ID: 3034405
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.
Chiao PJ; Kannan P; Yim SO; Krizman DB; Wu TA; Gallick GE; Tainsky MA
Oncogene; 1991 May; 6(5):713-20. PubMed ID: 1646984
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes.
Geiser AG; Anderson MJ; Stanbridge EJ
Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289
[TBL] [Abstract][Full Text] [Related]
10. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
11. Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells.
Buettner R; Yim SO; Hong YS; Boncinelli E; Tainsky MA
Mol Cell Biol; 1991 Jul; 11(7):3573-83. PubMed ID: 1675427
[TBL] [Abstract][Full Text] [Related]
12. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
13. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
[TBL] [Abstract][Full Text] [Related]
16. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
17. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
18. Altered growth regulation and loss of response to retinoic acid accompany tumorigenic transformation of prostatic cells.
Peehl DM; Sellers RG; Arnstein P; Kung HF; Rhim JS
Anticancer Res; 1999; 19(5B):3857-64. PubMed ID: 10628324
[TBL] [Abstract][Full Text] [Related]
19. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
[TBL] [Abstract][Full Text] [Related]
20. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
Jiang N; Zhan F; Cao L; Yao K; Li G
Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
